J.P. Morgan Private Wealth Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $5.95M | Buy |
+67,207
| New | +$5.95M | 0.02% | 471 |
|
|
2023
Q2 | – | Sell |
-14,764
| Closed | -$1.44M | – | 1531 |
|
|
2023
Q1 | $1.44M | Buy |
14,764
+1,691
| +13% | +$164K | ﹤0.01% | 1005 |
|
|
2022
Q4 | $1.35M | Buy |
13,073
+1,221
| +10% | +$126K | ﹤0.01% | 1008 |
|
|
2022
Q3 | $1.01M | Buy |
11,852
+1,474
| +14% | +$125K | ﹤0.01% | 1134 |
|
|
2022
Q2 | $860K | Sell |
10,378
-3,117
| -23% | -$258K | ﹤0.01% | 1215 |
|
|
2022
Q1 | $1.04M | Buy |
13,495
+2,306
| +21% | +$178K | ﹤0.01% | 1206 |
|
|
2021
Q4 | $989K | Sell |
11,189
-2,156
| -16% | -$191K | ﹤0.01% | 1248 |
|
|
2021
Q3 | $1.03M | Buy |
13,345
+3,041
| +30% | +$235K | ﹤0.01% | 1194 |
|
|
2021
Q2 | $860K | Buy |
10,304
+2
| +0% | +$167 | ﹤0.01% | 1260 |
|
|
2021
Q1 | $778K | Sell |
10,302
-2,045
| -17% | -$154K | ﹤0.01% | 1148 |
|
|
2020
Q4 | $1.08M | Sell |
12,347
-1,594
| -11% | -$140K | ﹤0.01% | 976 |
|
|
2020
Q3 | $1.06M | Buy |
13,941
+1,385
| +11% | +$105K | ﹤0.01% | 869 |
|
|
2020
Q2 | $1.55M | Buy |
12,556
+2,611
| +26% | +$322K | 0.01% | 656 |
|
|
2020
Q1 | $840K | Buy |
9,945
+1,205
| +14% | +$102K | ﹤0.01% | 764 |
|
|
2019
Q4 | $739K | Buy |
8,740
+1,026
| +13% | +$86.8K | ﹤0.01% | 903 |
|
|
2019
Q3 | $520K | Buy |
7,714
+880
| +13% | +$59.3K | ﹤0.01% | 989 |
|
|
2019
Q2 | $585K | Buy |
6,834
+887
| +15% | +$75.9K | ﹤0.01% | 926 |
|
|
2019
Q1 | $528K | Buy |
5,947
+1,780
| +43% | +$158K | ﹤0.01% | 1016 |
|
|
2018
Q4 | $355K | Sell |
4,167
-3,017
| -42% | -$257K | ﹤0.01% | 1090 |
|
|
2018
Q3 | $696K | Buy |
7,184
+434
| +6% | +$42K | ﹤0.01% | 952 |
|
|
2018
Q2 | $636K | Sell |
6,750
-367
| -5% | -$34.6K | ﹤0.01% | 924 |
|
|
2018
Q1 | $577K | Buy |
7,117
+4,503
| +172% | +$365K | ﹤0.01% | 821 |
|
|
2017
Q4 | $233K | Buy |
2,614
+245
| +10% | +$21.8K | ﹤0.01% | 1136 |
|
|
2017
Q3 | $220K | Buy |
+2,369
| New | +$220K | ﹤0.01% | 1126 |
|
|
2015
Q3 | – | Sell |
-1,585
| Closed | -$217K | – | 1065 |
|
|
2015
Q2 | $217K | Buy |
+1,585
| New | +$217K | ﹤0.01% | 948 |
|